Clairfield advises holding company of Medsen on its majority sale to Bencis

Zambon, an Italian pharmaceutical multinational, acquired the biotech Breath Therapeutics at an initial price of 140 million euros and with the possibility of reaching a total of 500 million euros at the achievement of regulatory and commercial objectives.

A stake in Veterinærmedisinsk Oppdragssenter AS (VESO), was sold by the  Norwegian Ministry of Trade, Industry and Fisheries (NFD) to Aquanova Invest. VESO distributes veterinary pharmaceuticals as well as performing clinical tests on fish for vaccine and feed development.

Celopharma, a distributor of female pharmaceutical products, was sold to Linepharma International Ltd., a US subsidiary of a Swiss-based pharmaceutical company.

Terry White Group (TWG), a pharmacy franchisor with a network of nearly 500 pharmacies across Australia, sold its remaining shares to EBOS Group, the largest and most diversified Australasian marketer, wholesaler, and distributor of healthcare, medical, and pharmaceutical products.

BJP Laboratories, a leading Australian contract manufacturer of listed medicines, sold 80% of its shares to DZG Investments, the Australian subsidiary of the Goubuli Group, a Chinese food and beverage company.